Pharmaceutical
| Fri 10 Apr 2026
Munich, April 11 -- Samsung Biologics Co Ltd has sought patent for CH3 Domain Variant or Bispecific Antibody Comprising Same. This invention was developed by Jung Woosuk, Kim Jungwon, Kim Migyeom, Kim Jina, Park Juhyun, Lee Sangho, Hong Hyebeen, Lee Soyeon, Park Sangyun, Yang Wooseok, Kang Seong Ho, Shin Gwangsu, Kim Mina, Kim J..